Nisa Investment Advisors Portfolio holdings
AUM
$22.2B
1-Year Return
21.03%
This Quarter Return
+10.4%
1 Year Return
+21.03%
3 Year Return
+95.61%
5 Year Return
+159.15%
10 Year Return
+382.87%
AUM
$13.3B
AUM Growth
+$13.3B
(+80,795%)
Cap. Flow
+$574M
Cap. Flow
% of AUM
4.3%
Top 10 Holdings %
Top 10 Hldgs %
21.46%
Holding
2,413
New
102
Increased
498
Reduced
1,008
Closed
275
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$297M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$295M |
| 3 |
NVIDIA
NVDA
|
+$51.8M |
| 4 |
NetEase
NTES
|
+$51.7M |
| 5 |
JD.com
JD
|
+$44.9M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$41.5M |
| 2 |
Microsoft
MSFT
|
+$38.6M |
| 3 |
Nike
NKE
|
+$29.7M |
| 4 |
Visa
V
|
+$21.2M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$16.7M |
Sector Composition
| 1 | Technology | 19.04% |
| 2 | Healthcare | 12.16% |
| 3 | Financials | 11.34% |
| 4 | Communication Services | 9.82% |
| 5 | Consumer Discretionary | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENV
1701
DELISTED
ENVESTNET, INC.
ENV
| $57K | ﹤0.01% |
770
-1,230
| -62% | -$91.1K |
|
1702
Diamond Hill
DHIL
$384M
| $56K | ﹤0.01% |
300
-200
| -40% | -$37.3K |
|
1703
Hope Bancorp
HOPE
$1.41B
| $56K | ﹤0.01% |
3,325
| – | – |
|
1704
Maravai LifeSciences
MRVI
$373M
| $56K | ﹤0.01% |
1,927
-2,344
| -55% | -$68.1K |
|
1705
Praxis Precision Medicines
PRAX
$834M
| $56K | ﹤0.01% |
+253
| New | +$56K |
|
1706
TriMas Corp
TRS
$1.56B
| $56K | ﹤0.01% |
1,620
-1,680
| -51% | -$58.1K |
|
|
WMC
1707
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $56K | ﹤0.01% |
2,550
| – | – |
|
1708
Cabot Corp
CBT
$4.23B
| $55K | ﹤0.01% |
1,000
| – | – |
|
1709
Palomar
PLMR
$3.18B
| $55K | ﹤0.01% |
1,050
| – | – |
|
1710
Snowflake
SNOW
$76.2B
| $55K | ﹤0.01% |
200
| – | – |
|
1711
Vanda Pharmaceuticals
VNDA
$266M
| $55K | ﹤0.01% |
3,640
-1,260
| -26% | -$19K |
|
1712
Academy Sports + Outdoors
ASO
$3.18B
| $54K | ﹤0.01% |
1,390
+1,240
| +827% | +$48.2K |
|
1713
Cerus
CERS
$228M
| $54K | ﹤0.01% |
10,040
+6,550
| +188% | +$35.2K |
|
1714
Kulicke & Soffa
KLIC
$1.97B
| $54K | ﹤0.01% |
990
+560
| +130% | +$30.5K |
|
1715
Phreesia
PHR
$1.52B
| $54K | ﹤0.01% |
1,740
-400
| -19% | -$12.4K |
|
1716
Protolabs
PRLB
$1.17B
| $54K | ﹤0.01% |
1,080
+750
| +227% | +$37.5K |
|
1717
Agios Pharmaceuticals
AGIO
$2.05B
| $53K | ﹤0.01% |
1,710
-1,120
| -40% | -$34.7K |
|
1718
CorVel
CRVL
$4.43B
| $53K | ﹤0.01% |
900
| – | – |
|
1719
Monarch Casino & Resort
MCRI
$1.86B
| $53K | ﹤0.01% |
860
| – | – |
|
1720
Kymera Therapeutics
KYMR
$3.11B
| $52K | ﹤0.01% |
1,227
+447
| +57% | +$18.9K |
|
1721
MaxCyte
MXCT
$150M
| $52K | ﹤0.01% |
+7,982
| New | +$52K |
|
1722
Quanterix
QTRX
$202M
| $52K | ﹤0.01% |
1,700
| – | – |
|
1723
Sunrun
RUN
$3.8B
| $52K | ﹤0.01% |
2,000
+565
| +39% | +$14.7K |
|
|
IMGN
1724
DELISTED
Immunogen Inc
IMGN
| $52K | ﹤0.01% |
9,260
-3,470
| -27% | -$19.5K |
|
1725
Coca-Cola Europacific Partners
CCEP
$40.3B
| $51K | ﹤0.01% |
900
| – | – |
|